Tag Archives: randomized clinical trial

Time to switch? Switching from innovator rituximab to biosimilar CT-P10 is safe and efficacious

Rituximab is a monoclonal antibody that targets the CD20 protein that is found mainly on immune cells called B lymphocytes. By removing CD20-positive B lymphocytes from the peripheral blood and bone marrow, rituximab provides effective treatment for

Long-term safety and efficacy of rituximab biosimilar CT-P10 in rheumatoid arthritis

Rituximab is a monoclonal antibody used to treat certain cancers of the blood, as well as immune-mediated diseases such as rheumatoid arthritis. But while rituximab is effective, it is also expensive, which means that not everyone who